Quarterly report pursuant to Section 13 or 15(d)

Revenue - Additional Information (Details)

v3.23.1
Revenue - Additional Information (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2023
USD ($)
Disaggregation of Revenue [Line Items]  
Non-cancellable backlog $ 1,396
Revenue recognized 660
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01  
Disaggregation of Revenue [Line Items]  
Remaining performance obligation, amount $ 1,080
Remaining performance obligation, period 9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01  
Disaggregation of Revenue [Line Items]  
Remaining performance obligation, amount $ 795
Remaining performance obligation, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01  
Disaggregation of Revenue [Line Items]  
Remaining performance obligation, amount $ 788
Remaining performance obligation, period
Minimum  
Disaggregation of Revenue [Line Items]  
Term of contract 12 months
Minimum | EksoHealth  
Disaggregation of Revenue [Line Items]  
Accounts receivable payment terms 12 months
Maximum  
Disaggregation of Revenue [Line Items]  
Term of contract 24 months
Maximum | EksoHealth  
Disaggregation of Revenue [Line Items]  
Accounts receivable payment terms 48 months